<乌鸦传媒>New Oral Drug Approved for Ulcerative Colitis in Adults S1P receptor modulator etrasimod indicated for moderately to severely active disease Oct 13, 2023
<乌鸦传媒>Atopic Dermatitis Linked to Increased IBD Risk in Adults and Kids Risk increased with severity of atopic dermatitis across both groups, cohort study shows Aug 30, 2023
<乌鸦传媒>U.S. Unveils First 10 Drugs for Medicare Price Negotiations Treatments for heart failure, Crohn's disease, and diabetes make the list Aug 29, 2023
<乌鸦传媒>Doctors, Patients Try to Shame Insurers to Reverse Prior Auth Denials Many have taken to social media to get tests, drugs, and treatments approved Aug 27, 2023
<乌鸦传媒>First Multiple Sclerosis Biosimilar Approved Natalizumab-sztn gets a nod from the FDA Aug 25, 2023
<乌鸦传媒>TNF Blockers for IBD Tied to Risk for Immune-Mediated Diseases "Paradoxical" finding puzzles researchers Jul 22, 2023
<乌鸦传媒>Mirikizumab Benefit in UC Extends Into Maintenance Phase Twice as many responders achieved clinical remission at week 40 versus placebo Jun 28, 2023
<乌鸦传媒>Inflammatory Bowel Disease Linked With Increased Stroke Risk Swedish study is largest, with longest follow-up to date Jun 14, 2023
<乌鸦传媒>A Close Look at the Data Backing Upadacitinib's Approval in Crohn's Compared with placebo, the JAK inhibitor improved clinical remission and endoscopic response May 25, 2023
<乌鸦传媒>First JAK Inhibitor Approved for Crohn's Disease Upadacitinib lands indication for moderately to severely active disease in adults May 18, 2023
<乌鸦传媒>Win for Vedolizumab in Recurrent Crohn's Disease Trial boosts case for label expansion May 08, 2023
<乌鸦传媒>Vedolizumab Proves Its Worth in Treating Chronic Pouchitis Biologic effective for common complication of ileal pouch-anal anastomosis in ulcerative colitis Mar 29, 2023
<乌鸦传媒>IL-6 Inhibitor for UC Shows Some Promise in Mid-Stage Trial Though next steps for olamkicept in ulcerative colitis a bit unclear Mar 07, 2023
<乌鸦传媒>Tyler James Williams' Crohn's Disease Golden Globe winner talks about his health ordeal Jan 25, 2023
<乌鸦传媒>IBD Interferes With Sleep Quality Intestinal as well as brain-related problems found in study that used wrist actigraphy devices Jan 23, 2023
<乌鸦传媒>IBD and Rheumatic Diseases Overlap Specialists in both fields need to communicate and coordinate, says researcher Jan 23, 2023
<乌鸦传媒>Hyperbaric Oxygen Therapy Promising for Crohn's Fistulas Literature review highlights benefits, although access is an issue, expert says Jan 22, 2023
<乌鸦传媒>Patients With Celiac and Overlap IBD Skip Out on Gluten-Free Diets Study finds no appetite for long-term adherence; lack of targeted education Jan 22, 2023
<乌鸦传媒>Wearable Tech Shows Promise for Predicting IBD Flares App measured heart rate variability metrics in patients with Crohn's, ulcerative colitis Jan 21, 2023
<乌鸦传媒>Contrary to Guidelines, 5-ASA Often Prescribed in Pediatric Crohn's Disease Use at diagnosis associated with delays in starting biologics Jan 20, 2023
<乌鸦传媒>IBD Risk Higher After Antibiotics Dose-response relationship found, especially for older individuals Jan 09, 2023
<乌鸦传媒>It's a TNF Inhibitor! It's a Steroid! It's Two (Potential) RA Drugs in One! Hints in mid-stage trial that novel conjugate will surpass adalimumab in efficacy Dec 14, 2022
<乌鸦传媒>Small Study Shows Most Crohn's Patients With Anal Cancer Survived 15 of 24 were alive and cancer free at 5.5 years of follow-up Dec 09, 2022
<乌鸦传媒>Antibiotic Exposure Before Age 2 Tied to Increased Risk of Pediatric IBD Even exposure during the last trimester of pregnancy increases this risk, researchers say Dec 08, 2022
<乌鸦传媒>Do Kidney Transplant Medications Supplant IBD Drugs? Study shows many patients no longer need drugs to help keep gut disease in check Dec 08, 2022
<乌鸦传媒>Joint Pain Linked to Worse Quality of Life in Ulcerative Colitis Patients Pain tied to increased risks of depression, anxiety, fatigue, and social impairment Dec 08, 2022
<乌鸦传媒>COVID-19 Booster Vaccine Appears Safe for IBD Patients Third shot reactions mirror earlier primary doses, study showed Dec 07, 2022
<乌鸦传媒>Infliximab Maintenance Home Infusion Appears Safe Few serious adverse events occurred in patient-friendly settings Dec 07, 2022
<乌鸦传媒>Xeljanz Cancer Risks Detailed New paper provides full results from ORAL Surveillance trial Dec 07, 2022
<乌鸦传媒>Upadacitinib Induction Provided Fast Symptom Relief in Ulcerative Colitis Post-hoc analysis showed symptom relief as early as day 1 with the JAK inhibitor Dec 02, 2022
<乌鸦传媒>Nearly 1 in 7 Adults Experience Bloating on Any Given Week Some individuals report feeling uncomfortable discussing it with their doctors Nov 17, 2022
<乌鸦传媒>Pandemic's Impact on Liver Disease in the Spotlight at Liver Meeting A roundup of news from the AASLD annual meeting Nov 04, 2022
<乌鸦传媒>Continuing Ozanimod Prevented More Relapses in Ulcerative Colitis Disease control also maintained with temporary withdrawal, at least initially Oct 28, 2022
<乌鸦传媒>Upadacitinib Maintenance Triples Clinical Remissions in Crohn's Disease U-ENDURE trial also hit co-primary endpoint for endoscopic response Oct 27, 2022
<乌鸦传媒>Two More IBD Drugs Cleared for Safety During Pregnancy Ustekinumab, vedolizumab not linked to greater risk of complications Oct 26, 2022
<乌鸦传媒>Guselkumab-Golimumab Combo Shows Promise for Ulcerative Colitis More clinical remissions, endoscopic improvements, early trial finds Oct 26, 2022
<乌鸦传媒>Higher Upadacitinib Dose May Be Better for UC Maintenance Post-hoc analysis suggested less severe disease and longer remission over 1 year Oct 24, 2022
<乌鸦传媒>Do Crohn's Patients Do Better With Early Surgery? Danish study finds fewer reoperations, though higher risk for hospitalization Oct 20, 2022
<乌鸦传媒>Eating More Unprocessed Foods Tied to Lower Risk of Crohn's Disease No association seen for ulcerative colitis, however Oct 14, 2022
<乌鸦传媒>Some Environmental Pollutants Linked to IBS PM2.5, airborne toxic releases associated with zip code-level IBS incidence in California Oct 04, 2022
